Why is Krebs Biochem falling/rising?

As of 30-Jul, Krebs Biochemicals & Industries Ltd's stock price is currently at 77.79, reflecting an increase of 1.42 or 1.86%. Despite this positive movement today, the stock has shown a significant decline over the past week, down 3.93%, and a more considerable drop of 11.40% over the past month. The stock is trading below all its moving averages, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 205.09% compared to the 5-day average. The company's fundamentals are concerning, as it has a negative book value and has reported negative results for the last two consecutive quarters, contributing to its classification as a strong sell.
In the broader market context, Krebs Biochem's recent performance contrasts with the benchmark, as it has underperformed the Sensex, which has seen a decline of only 1.45% over the past week. The stock's year-to-date performance is particularly troubling, with a decline of 16.35% compared to the Sensex's gain of 5.12%. This consistent underperformance against the benchmark over the last three years highlights the company's weak long-term growth prospects, exacerbated by high debt levels and negative EBITDA. Overall, while there is a slight uptick in the stock price today, the underlying fundamentals and broader market trends suggest a challenging environment for Krebs Biochemicals & Industries Ltd.